Incyte (INCY) Interest Expenses (2010 - 2026)
Incyte posted quarterly Interest Expenses of $569000.0 for Q1 2026, down 13.79% year-on-year from $660000.0 in Q1 2025, and down 2.23% on a QoQ basis from $582000.0 in Q4 2025.
Incyte (INCY) has 17 years of Interest Expenses data on file, last reported at $569000.0 in Q1 2026.
- For the quarter ending Q1 2026, Interest Expenses fell 13.79% year-over-year to $569000.0; the trailing twelve-month figure through Mar 2026 stood at $2.3 million (down 6.89% YoY), and the FY2025 full-year result was $2.4 million, up 6.49% from the prior year.
- Interest Expenses for Q1 2026 stood at $569000.0, down from $582000.0 in the prior quarter.
- Across five years, Interest Expenses topped out at $804000.0 in Q4 2023 and bottomed at $419000.0 in Q4 2024.
- The 5-year median for Interest Expenses is $641000.0 (2022), against an average of $617294.1.
- The widest annual swing landed in 2022, when Interest Expenses soared 89.42%; it then slumped 47.89% in 2024.
- A 5-year view of Interest Expenses shows it stood at $667000.0 in 2022, then grew by 20.54% to $804000.0 in 2023, then plunged by 47.89% to $419000.0 in 2024, then soared by 38.9% to $582000.0 in 2025, then retreated by 2.23% to $569000.0 in 2026.
- The last three Interest Expenses figures came in at $569000.0 (Q1 2026), $582000.0 (Q4 2025), and $592000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 22,854.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -5.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 61,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | -332,000.00 |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 12.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 69.29 Mn |
| 10 | Incyte | 19.28 Bn | 15.27 Bn | 1.17 Bn | 569,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 569,000.00 |
| Mar 31, 2026 | 569,000.00 |
| Dec 31, 2025 | 582,000.00 |
| Dec 31, 2025 | 582,000.00 |
| Sep 30, 2025 | 592,000.00 |
| Sep 30, 2025 | 592,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Jun 30, 2025 | 594,000.00 |
| Mar 31, 2025 | 660,000.00 |
| Mar 31, 2025 | 660,000.00 |
| Dec 31, 2024 | 419,000.00 |
| Dec 31, 2024 | 419,000.00 |
| Sep 30, 2024 | 774,000.00 |
| Sep 30, 2024 | 774,000.00 |
| Jun 30, 2024 | 657,000.00 |
| Jun 30, 2024 | 657,000.00 |
| Mar 31, 2024 | 430,000.00 |
| Mar 31, 2024 | 430,000.00 |
| Dec 31, 2023 | 804,000.00 |
| Dec 31, 2023 | 804,000.00 |
| Sep 30, 2023 | 623,000.00 |
| Sep 30, 2023 | 623,000.00 |
| Jun 30, 2023 | 655,000.00 |
| Jun 30, 2023 | 655,000.00 |
| Mar 31, 2023 | 469,000.00 |
| Mar 31, 2023 | 469,000.00 |
| Dec 31, 2022 | 667,000.00 |
| Dec 31, 2022 | 667,000.00 |
| Sep 30, 2022 | 641,000.00 |
| Sep 30, 2022 | 641,000.00 |
| Jun 30, 2022 | 678,000.00 |
| Jun 30, 2022 | 678,000.00 |
| Mar 31, 2022 | 680,000.00 |
| Mar 31, 2022 | 680,000.00 |
| Dec 31, 2021 | 752,000.00 |
| Dec 31, 2021 | 752,000.00 |
| Sep 30, 2021 | 439,000.00 |
| Sep 30, 2021 | 439,000.00 |
| Jun 30, 2021 | 358,000.00 |
| Jun 30, 2021 | 358,000.00 |
| Mar 31, 2021 | 359,000.00 |
| Mar 31, 2021 | 359,000.00 |
| Dec 31, 2020 | 428,000.00 |
| Dec 31, 2020 | 428,000.00 |
| Sep 30, 2020 | 544,000.00 |
| Sep 30, 2020 | 544,000.00 |
| Jun 30, 2020 | 600,000.00 |
| Jun 30, 2020 | 600,000.00 |
| Mar 31, 2020 | 602,000.00 |
| Mar 31, 2020 | 602,000.00 |
| Dec 31, 2019 | 607,000.00 |
| Dec 31, 2019 | 607,000.00 |
| Sep 30, 2019 | 597,000.00 |
| Sep 30, 2019 | 597,000.00 |
| Jun 30, 2019 | 316,000.00 |
| Jun 30, 2019 | 316,000.00 |
| Mar 31, 2019 | 335,000.00 |
| Mar 31, 2019 | 335,000.00 |
| Dec 31, 2018 | 355,000.00 |
| Dec 31, 2018 | 355,000.00 |
| Sep 30, 2018 | 405,000.00 |
| Sep 30, 2018 | 405,000.00 |
| Jun 30, 2018 | 398,000.00 |
| Jun 30, 2018 | 398,000.00 |
| Mar 31, 2018 | 385,000.00 |
| Mar 31, 2018 | 385,000.00 |
| Dec 31, 2017 | 373,000.00 |
| Dec 31, 2017 | 373,000.00 |
| Sep 30, 2017 | 204,000.00 |
| Sep 30, 2017 | 204,000.00 |
| Jun 30, 2017 | 384,000.00 |
| Jun 30, 2017 | 384,000.00 |
| Mar 31, 2017 | 5.94 Mn |
| Mar 31, 2017 | 5.94 Mn |
| Dec 31, 2016 | 9.47 Mn |
| Dec 31, 2016 | 9.47 Mn |
| Sep 30, 2016 | 9.48 Mn |
| Sep 30, 2016 | 9.48 Mn |
| Jun 30, 2016 | 9.66 Mn |
| Jun 30, 2016 | 9.66 Mn |
| Mar 31, 2016 | 10.13 Mn |
| Mar 31, 2016 | 10.13 Mn |
| Dec 31, 2015 | 10.21 Mn |
| Dec 31, 2015 | 10.21 Mn |
| Sep 30, 2015 | 11.21 Mn |
| Sep 30, 2015 | 11.21 Mn |
| Jun 30, 2015 | 11.49 Mn |
| Jun 30, 2015 | 11.49 Mn |
| Mar 31, 2015 | 12.69 Mn |
| Mar 31, 2015 | 12.69 Mn |
| Dec 31, 2014 | 12.52 Mn |
| Dec 31, 2014 | 12.52 Mn |
| Sep 30, 2014 | 11.46 Mn |
| Sep 30, 2014 | 11.46 Mn |
| Jun 30, 2014 | 11.41 Mn |
| Jun 30, 2014 | 11.41 Mn |
| Mar 31, 2014 | 11.44 Mn |
| Mar 31, 2014 | 11.44 Mn |
| Dec 31, 2013 | 8.93 Mn |
| Dec 31, 2013 | 8.93 Mn |
| Sep 30, 2013 | 7.70 Mn |
| Sep 30, 2013 | 7.70 Mn |
| Jun 30, 2013 | 10.29 Mn |
| Jun 30, 2013 | 10.29 Mn |
| Mar 31, 2013 | 11.73 Mn |
| Mar 31, 2013 | 11.73 Mn |
| Dec 31, 2012 | 11.77 Mn |
| Dec 31, 2012 | 11.77 Mn |
| Sep 30, 2012 | 11.57 Mn |
| Sep 30, 2012 | 11.57 Mn |
| Jun 30, 2012 | 11.43 Mn |
| Jun 30, 2012 | 11.43 Mn |
| Mar 31, 2012 | 11.29 Mn |
| Mar 31, 2012 | 11.29 Mn |
| Dec 31, 2011 | 11.15 Mn |
| Dec 31, 2011 | 11.15 Mn |
| Sep 30, 2011 | 11.02 Mn |
| Sep 30, 2011 | 11.02 Mn |
| Jun 30, 2011 | 10.89 Mn |
| Jun 30, 2011 | 10.89 Mn |
| Mar 31, 2011 | 10.76 Mn |
| Mar 31, 2011 | 10.76 Mn |
| Dec 31, 2010 | 10.64 Mn |
| Dec 31, 2010 | 10.64 Mn |
| Sep 30, 2010 | 10.52 Mn |
| Sep 30, 2010 | 10.52 Mn |
| Jun 30, 2010 | 10.39 Mn |
| Jun 30, 2010 | 10.39 Mn |
| Mar 31, 2010 | 11.78 Mn |
| Mar 31, 2010 | 11.78 Mn |